545 related articles for article (PubMed ID: 24123565)
1. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
[TBL] [Abstract][Full Text] [Related]
2. Human steroid sulfatase enhances aerobic glycolysis through induction of HIF1α and glycolytic enzymes.
Shin S; Kwon YJ; Ye DJ; Baek HS; Kwon TU; Kim D; Chun YJ
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2464-2474. PubMed ID: 31195119
[TBL] [Abstract][Full Text] [Related]
3. Mitofusins deficiency elicits mitochondrial metabolic reprogramming to pluripotency.
Son MJ; Kwon Y; Son MY; Seol B; Choi HS; Ryu SW; Choi C; Cho YS
Cell Death Differ; 2015 Dec; 22(12):1957-69. PubMed ID: 25882047
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
5. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells.
de Wit RH; Mujić-Delić A; van Senten JR; Fraile-Ramos A; Siderius M; Smit MJ
Oncotarget; 2016 Oct; 7(42):67966-67985. PubMed ID: 27602585
[TBL] [Abstract][Full Text] [Related]
6. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma.
Xiaoyu H; Yiru Y; Shuisheng S; Keyan C; Zixing Y; Shanglin C; Yuan W; Dongming C; Wangliang Z; Xudong B; Jie M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818780063. PubMed ID: 29916308
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency.
Mathieu J; Zhou W; Xing Y; Sperber H; Ferreccio A; Agoston Z; Kuppusamy KT; Moon RT; Ruohola-Baker H
Cell Stem Cell; 2014 May; 14(5):592-605. PubMed ID: 24656769
[TBL] [Abstract][Full Text] [Related]
8. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation.
Regan JN; Lim J; Shi Y; Joeng KS; Arbeit JM; Shohet RV; Long F
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8673-8. PubMed ID: 24912186
[TBL] [Abstract][Full Text] [Related]
10. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.
Shi LZ; Wang R; Huang G; Vogel P; Neale G; Green DR; Chi H
J Exp Med; 2011 Jul; 208(7):1367-76. PubMed ID: 21708926
[TBL] [Abstract][Full Text] [Related]
11. Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
Peng F; Wang JH; Fan WJ; Meng YT; Li MM; Li TT; Cui B; Wang HF; Zhao Y; An F; Guo T; Liu XF; Zhang L; Lv L; Lv DK; Xu LZ; Xie JJ; Lin WX; Lam EW; Xu J; Liu Q
Oncogene; 2018 Feb; 37(8):1062-1074. PubMed ID: 29106390
[TBL] [Abstract][Full Text] [Related]
12. Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1.
Kumar P; Gullberg U; Olsson I; Ajore R
PLoS One; 2015; 10(5):e0123725. PubMed ID: 25974097
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity Tyrosine Phosphorylation-regulated Kinase Inhibitor ID-8 Promotes Human Somatic Cell Reprogramming by Activating PDK4 Expression.
Xu J; Fang S; Wang N; Li B; Huang Y; Fan Q; Shi J; Liu H; Shao Z
Stem Cell Rev Rep; 2022 Aug; 18(6):2074-2087. PubMed ID: 35080746
[TBL] [Abstract][Full Text] [Related]
15. A PKM2 signature in the failing heart.
Rees ML; Subramaniam J; Li Y; Hamilton DJ; Frazier OH; Taegtmeyer H
Biochem Biophys Res Commun; 2015 Apr; 459(3):430-6. PubMed ID: 25735978
[TBL] [Abstract][Full Text] [Related]
16. NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.
Hawkins KE; Joy S; Delhove JM; Kotiadis VN; Fernandez E; Fitzpatrick LM; Whiteford JR; King PJ; Bolanos JP; Duchen MR; Waddington SN; McKay TR
Cell Rep; 2016 Mar; 14(8):1883-91. PubMed ID: 26904936
[TBL] [Abstract][Full Text] [Related]
17. Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis.
Goodwin J; Choi H; Hsieh MH; Neugent ML; Ahn JM; Hayenga HN; Singh PK; Shackelford DB; Lee IK; Shulaev V; Dhar S; Takeda N; Kim JW
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):216-231. PubMed ID: 28915065
[TBL] [Abstract][Full Text] [Related]
18. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
Zhao H; Jiang R; Feng Z; Wang X; Zhang C
J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
[TBL] [Abstract][Full Text] [Related]
20. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
